BERLIN, April 26, 2009 (GLOBE NEWSWIRE) -- Jerini AG's Supervisory Board approved on Friday, April 24, 2009, the Management Board's decision of April 24, 2009 to wind down the operations of Jerini Ophthalmic, Inc., New York, USA, a subsidiary of Jerini AG. The decision was taken following unsuccessful efforts to find an investor for the sale of Jerini Ophthalmic, Inc. Given the substantial investments required and the Company's interests, a continuation of Jerini Ophthalmic, Inc.'s operations would be unjustified. The decision to wind down the operations of Jerini Ophthalmic, Inc. is expected to entail impairments of investments on the level of Jerini AG of up to EUR 6.8 million. The costs of closing the operations of Jerini Ophthalmic, Inc. are presently expected to amount to approximately EUR 1.4 million.
Jerini AG The Management Board ISIN: DE0006787476 WKN: 678 747 Regulated Market / Prime Standard; Frankfurt Stock Exchange, Germany Registered Office: Berlin, Germany